Skip to main content

Tuberculosis

  • Chapter
  • First Online:
Dermatology in Public Health Environments

Abstract

The number of cases of cutaneous tuberculosis (CTB) is increasing concomitantly with the increase of pulmonary tuberculosis. Migration, increasing immunosuppression factors, and treatment resistance are mainly responsible for this growth. The varied clinical presentation and low sensitivity of conventional tests make CTB a disease difficult to confirm in many cases. Most histopathologic examination has classic findings; however, bacilli frequency is low and atypical granulomas may occur. New tests with lower error rate and higher accuracy are available and should become known. The list of diseases that are differential diagnosis is extensive and beyond the shape of the skin lesion, depending on the location and age. The initial treatment is equal to the pulmonary tuberculosis, but has some particularities, as difficulty in confirming possible drugs’ resistance. This knowledge is essential for coping with the disease in the current scenario.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AFB:

Acid-fast bacillus

AIDS:

Acquired immunodeficiency syndrome

AMTDT:

Amplified Mycobacterium tuberculosis Direct Test

BCG:

Bacillus Calmette-Guérin

COVID-19:

Coronavirus disease 2019

CTB:

Cutaneous tuberculosis

EIB:

Erythema Induratum of Bazin

EN:

Erythema nodosum

HIV:

Human immunodeficiency virus

IGRA:

Interferon-γ release assay

IL:

Interleukin

INF:

Interferon

LV:

Lupus vulgaris

MAC:

M. avium-intracellulare complex

MDA:

Multiple displacement amplification

MTB:

Mycobacterium tuberculosis

MTC:

Mycobacterium tuberculosis complex

NSAIDs:

Nonsteroidal anti-inflammatory drugs

NTM:

Nontuberculous mycobacteria

PCR:

Polymerase chain reaction

PPD:

Purified protein derivative

RHZ:

Rifampicin, isoniazid, and pyrazinamide

SARS-CoV-19:

Severe acute respiratory syndrome coronavirus 2

TB:

Tuberculosis

TGF:

Transforming growth factor

Th:

T-helper

TST:

Tuberculin skin test

TVC:

Tuberculosis verrucosa cutis

WHO:

World Health Organization

References

  1. World Health Organization. Tuberculosis (TB). Global tuberculosis report 2020. https://www.who.int/health-topics/tuberculosis#tab=tab_1. Accessed 11 Dec 2020.

  2. Centers for Disease Control and Prevention. Tuberculosis (TB). https://www.cdc.gov/tb/. Accessed 11 Dec 2020.

  3. Silva DR, Mello FCQ, Migliori GB. Tuberculosis series 2020. J Bras Pneumol. 2020;46(2):e20200027. https://doi.org/10.36416/1806-3756/e20200027.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Tortoli E, Meehan CJ, Grottola A, Serpini GF, et al. Genome-based taxonomic revision detects a number of synonymous taxa in the genus Mycobacterium. Infect Genet Evol. 2019;75:103983. https://doi.org/10.1016/j.meegid.2019.103983.

    Article  CAS  PubMed  Google Scholar 

  5. Gupta RS, Lo B, Son J. Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera. Front Microbiol. 2018;9:67. https://doi.org/10.3389/fmicb.2018.00067.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kazda J, Pavlik I. Obligate pathogenic mycobacteria. In: Kazda J, Pavlik I, Falkinham III JO, Hruska K, editors. The ecology of mycobacteria: impact on animal’s and human’s health. Netherlands: Springer; 2009. p. 13–20. https://doi.org/10.1007/978-1-4020-9413-2.

    Chapter  Google Scholar 

  7. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City—turning the tide. N Engl J Med. 1995;333(4):229–33. https://doi.org/10.1056/NEJM199507273330406.

    Article  CAS  PubMed  Google Scholar 

  8. Waaler HT. Tuberculosis and poverty. Int J Tuberc Lung Dis. 2002;6(9):745–6.

    PubMed  Google Scholar 

  9. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16(3):463–96. https://doi.org/10.1128/CMR.16.3.463-496.2003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Brosch R, Gordon SV, Marmiesse M, Brodin P, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. PNAS. 2002;99(6):3684–9. https://doi.org/10.1073/pnas.052548299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, et al. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects—part I. An Bras Dermatol. 2014;89(2):219–28. https://doi.org/10.1590/abd1806-4841.20142334.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kumar DR, Bhattacharya DB, Meena DV, Soneja DM, Wig DN. COVID-19 and TB co-infection—‘Finishing touch’ in perfect recipe to ‘severity’ or ‘death’. J Infect. 2020;81(3):e39–40. https://doi.org/10.1016/j.jinf.2020.06.062.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dias MF, Bernardes Filho F, Quaresma MV, Nascimento LV, et al. Update on cutaneous tuberculosis. An Bras Dermatol. 2014;89(6):925–38. https://doi.org/10.1590/abd1806-4841.20142998e.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Singal A, Sonthalia S. Cutaneous tuberculosis in children: the Indian perspective. Indian J Dermatol Venereol Leprol. 2010;76(5):494–503. https://doi.org/10.4103/0378-6323.69060.

    Article  PubMed  Google Scholar 

  15. Barbagallo J, Tager P, Ingleton R, Hirsch RJ, et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol. 2002;3(5):319–28. https://doi.org/10.2165/00128071-200203050-00004.

    Article  PubMed  Google Scholar 

  16. Abebe F, Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol. 2009;157(2):235–43. https://doi.org/10.1111/j.1365-2249.2009.03967.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lai-Cheong JE, Perez A, Tang V, et al. Cutaneous manifestations of tuberculosis. Clin Exp Dermatol. 2007;32(4):461–6. https://doi.org/10.1111/j.1365-2230.2007.02352.x.

    Article  CAS  PubMed  Google Scholar 

  18. Frankel A, Penrose C, Emer J. Cutaneous tuberculosis: a practical case report and review for the dermatologist. J Clin Aesthet Dermatol. 2009;2(10):19–27. PMID: 20725570.

    PubMed  PubMed Central  Google Scholar 

  19. World Health Organization. Tuberculosis (TB). Childhood tuberculosis. http://www.who.int/tb/areas-of-work/children/en/. Accessed 10 Dec 2020.

  20. Brasil. Ministério da Saúde. Portal da Saúde. Tuberculose. Brasília; 2016. http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o-ministerio/741-secretaria-svs/vigilancia-de-a-a-z/tuberculose/11485-situacao-epidemiologica-dados. Accessed 10 Dec 2020.

  21. Centers for Disease Control and Prevention. Tuberculosis (TB). Children. http://www.cdc.gov/tb/topic/populations/TBinChildren/default.htm. Accessed 11 Dec 2020.

  22. Euzéby JP. List of prokaryotic names with standing in nomenclature (LPSN). https://lpsn.dsmz.de/genus/mycobacterium. Accessed 9 Dec 2020.

  23. Jagielski T, van Ingen J, Rastogi N, Dziadek J, et al. Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int. 2014;2014:645802. https://doi.org/10.1155/2014/645802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pavlik I, Falkinham JO III, Kazda J. Potentially pathogenic mycobacteria. In: Kazda J, Pavlik I, Falkinham III JO, Hruska K, editors. The ecology of mycobacteria: impact on animal’s and human’s health. Dordrecht: Springer; 2009. p. 21–79. https://doi.org/10.1007/978-1-4020-9413-2.

    Chapter  Google Scholar 

  25. Saini C, Kumar P, Tarique M, Sharma A, et al. Regulatory T cells antagonize proinflammatory response of IL-17 during cutaneous tuberculosis. J Inflamm Res. 2018;11:377–88. https://doi.org/10.2147/JIR.S172878.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sekiguchi A, Motegi S, Ishikawa O. Erythema induratum of Bazin associated with bacillus Calmette-Guérin vaccination: implication of M1 macrophage infiltration and monocyte chemotactic protein-1 expression. J Dermatol. 2016;43(1):111–3. https://doi.org/10.1111/1346-8138.13148.

    Article  PubMed  Google Scholar 

  27. Huang Z, Luo Q, Guo Y, et al. Mycobacterium tuberculosis-induced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro. PLoS One. 2015;10(6):e0129744. https://doi.org/10.1371/journal.pone.0129744.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Piccoli BTB, Mainetti C, Peeters MA, Laffitte E. Cutaneous granulomatosis: a comprehensive review. Clin Rev Allergy Immunol. 2018;54(1):131–46. https://doi.org/10.1007/s12016-017-8666-8.

    Article  CAS  Google Scholar 

  29. Paredes CF, Marcos LA, Martínez AFH, Morales AJR, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2018;32(1):e00069–18. https://doi.org/10.1128/CMR.00069-18.

    Article  Google Scholar 

  30. Chen Q, Chen W, Hao F. Cutaneous tuberculosis: a great imitator. Clin Dermatol. 2019;37:192–9. https://doi.org/10.1016/j.clindermatol.2019.01.008.

    Article  PubMed  Google Scholar 

  31. Sehgal VN, Bhattacharya SN, Jain S, Logani K. Cutaneous tuberculosis: the evolving scenario. Int J Dermatol. 1994;33(2):97–105. https://doi.org/10.1111/j.1365-4362.1994.tb01534.x.

    Article  CAS  PubMed  Google Scholar 

  32. Concha RM, Fich FS, Rabagliati RB, Pinto CS, et al. Cutaneous tuberculosis: two case reports and review. Rev Chilena Infectol. 2011;28(3):262–8. https://doi.org/10.4067/S0716-10182011000300011.

    Article  Google Scholar 

  33. Collins FM. Tuberculosis research in a cold climate. Tuber Lung Dis. 1998;78(2):99–107. https://doi.org/10.1016/S0962-8479(98)80002-6.

    Article  Google Scholar 

  34. Fortaleza GTM, Brito MFM, Santos JB, Figueiredo AR, et al. Splenic tuberculosis during psoriasis treatment with infliximab. An Bras Dermatol. 2009;84:420–4. https://doi.org/10.1590/S0365-05962009000400016.

    Article  PubMed  Google Scholar 

  35. Puri N. A clinical and histopathological profile of patients with cutaneous tuberculosis. Indian J Dermatol. 2011;56:550–2. https://doi.org/10.4103/0019-5154.87153.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Murry WT, Sharma S, Arora VK, Bhattacharya SN, et al. Cytomorphological spectrum and immunochemistry of cutaneous tuberculosis. Diagn Cytopathol. 2018;47(5):458–68. https://doi.org/10.1002/dc.24138.

    Article  PubMed  Google Scholar 

  37. Sethuraman G, Ramesh V. Cutaneous tuberculosis in children. Pediatr Dermatol. 2013;30(1):7–16. https://doi.org/10.1111/j.1525-1470.2012.01794.x.

    Article  PubMed  Google Scholar 

  38. Zhang J, Fan YK, Wang P, Chen QQ, et al. Cutaneous tuberculosis in China—a multicentre retrospective study of cases diagnosed between 1957 and 2013. J Eur Acad Dermatol Venereol. 2018;32(4):632–8. https://doi.org/10.1111/jdv.14851.

    Article  CAS  PubMed  Google Scholar 

  39. Spelta K, Diniz LM. Cutaneous tuberculosis: a 26-year retrospective study in an endemic area of tuberculosis, Vitória, Espírito Santo, Brazil. Rev Inst Med Trop São Paulo. 2016;58:49. https://doi.org/10.1590/S1678-9946201658049.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Mervis JS, Machler BC, Hanly AJ, Federman DG. Down the rabbit hole: cutaneous tuberculosis. Am J Med. 2018;132(1):52–4. https://doi.org/10.1016/j.amjmed.2018.08.016.

    Article  PubMed  Google Scholar 

  41. Mann D, Sant’Anna FM, Schmaltz CAS, Freitas DFS, et al. Cutaneous tuberculosis and HIV infection at a referral centre in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2018;113(9):180–4. https://doi.org/10.1590/0074-02760180184.

    Article  Google Scholar 

  42. Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clin Dermatol. 2007;25(2):173–80. https://doi.org/10.1016/j.clindermatol.2006.05.005.

    Article  PubMed  Google Scholar 

  43. Handog EB, Gabriel TG, Pineda RTV. Management of cutaneous tuberculosis. Dermatol Ther. 2008;21(3):154–61. https://doi.org/10.1111/j.1529-8019.2008.00186.x.

    Article  PubMed  Google Scholar 

  44. van Zyl L, du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis. 2015;95(6):629–38. https://doi.org/10.1016/j.tube.2014.12.006.

    Article  PubMed  Google Scholar 

  45. Sethi A. Tuberculosis and infections with atypical mycobacteria. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick’s dermatology. 9th ed. Baltimore: McGraw-Hill Education; 2019. p. 2858–75. isbn:978-0-07-183783-5.

    Google Scholar 

  46. MacGregor RR. Cutaneous tuberculosis. Clin Dermatol. 1995;13(3):245–55. https://doi.org/10.1016/0738-081x(95)00019-c.

    Article  CAS  PubMed  Google Scholar 

  47. Wong HW, Tay YK, Sim CS. Papular eruption on a tattoo: a case of primary inoculation tuberculosis. Australas J Dermatol. 2005;46(2):84–7. https://doi.org/10.1111/j.1440-0960.2005.00147.x.

    Article  PubMed  Google Scholar 

  48. Kumar B, Rai R, Kaur I, Sahoo B, et al. Childhood cutaneous tuberculosis: a study over 25 years from northern India. Int J Dermatol. 2001;40(1):26–32. https://doi.org/10.1046/j.1365-4362.2001.01165.x.

    Article  CAS  PubMed  Google Scholar 

  49. Nakamura S, Hashimoto Y, Nishi K, Takahashi H, et al. Cutaneous tuberculosis simulating lymphocutaneous sporotrichosis. Australas J Dermatol. 2012;53(4):136–7. https://doi.org/10.1111/j.1440-0960.2012.00957.x.

    Article  Google Scholar 

  50. Sehgal VN, Sehgal R, Bajaj P, Sriviastava G, et al. Tuberculosis verrucosa cutis (TBVC). J Eur Acad Dermatol Venereol. 2000;14(4):319–21. https://doi.org/10.1046/j.1468-3083.2000.00075-6.x.

    Article  CAS  PubMed  Google Scholar 

  51. Gruber PC, Whittam LR, du Vivier A. Tuberculosis verrucosa cutis on the sole of the foot. Clin Exp Dermatol. 2002;27(3):188–91. https://doi.org/10.1046/j.1365-2230.2002.00994.x.

    Article  CAS  PubMed  Google Scholar 

  52. Chahar M, Dhali TK, D’Souza P. Multifocal tuberculosis verrucosa cútis. Dermatol Online J. 2015;21(1):13030/qt80j7q792. PMID: 25612118.

    Article  PubMed  Google Scholar 

  53. Vashisht P, Sahoo B, Khurana N, Reddy BS. Cutaneous tuberculosis in children and adolescents: a clinicohistological study. J Eur Acad Dermatol Venereol. 2007;21(1):40–7. https://doi.org/10.1111/j.1468-3083.2006.01858.x.

    Article  CAS  PubMed  Google Scholar 

  54. Bellet JS, Prose NS. Skin complications of Bacillus Calmette-Guérin immunization. Curr Opin Infect Dis. 2005;18(2):97–100. https://doi.org/10.1097/01.qco.0000160895.97362.4f.

    Article  PubMed  Google Scholar 

  55. Yates VM, Walker SL. Chapter 27. Mycobacterial infections. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. 9th ed. Oxford: Blackwell Publishing Ltd; 2016. p. 27.5–27.32. isbn:9781118441190.

    Google Scholar 

  56. Saritha M, Parveen BA, Anandan V, Priyavathani MR, et al. Atypical forms of lupus vulgaris—a case series. Int J Dermatol. 2009;48(2):150–3. https://doi.org/10.1111/j.1365-4632.2009.03863.x.

    Article  PubMed  Google Scholar 

  57. Ramesh V. Sporotrichoid cutaneous tuberculosis. Clin Exp Dermatol. 2007;32(6):680–2. https://doi.org/10.1111/j.1365-2230.2007.02481.x.

    Article  CAS  PubMed  Google Scholar 

  58. Motta A, Feliciani P, Toto P, De Benedetto A, et al. Lupus vulgaris developing at the site of misdiagnosed scrofuloderma. J Eur Acad Dermatol Venereol. 2003;17(3):313–5. https://doi.org/10.1046/j.1468-3083.2003.00783.x.

    Article  CAS  PubMed  Google Scholar 

  59. Gooptu C, Marks N, Thomas J, James MP. Squamous cell carcinoma associated with lupus vulgaris. Clin Exp Dermatol. 1998;23(3):99–102. https://doi.org/10.1046/j.1365-2230.1998.00346.x.

    Article  CAS  PubMed  Google Scholar 

  60. Zawirska A, Adamski Z, Stawicka E, Schwartz RA. Cutaneous squamous cell carcinoma developing in lupus vulgaris exfoliativus persistent for 40 years. Int J Dermatol. 2009;48(2):125–7. https://doi.org/10.1111/j.1365-4632.2009.03850.x.

    Article  PubMed  Google Scholar 

  61. Pacheco C, Silva E, Miranda J, Duarte R. Cutaneous tuberculosis as metastatic tuberculous abscess. J Bras Pneumol. 2015;41(2):200–2. https://doi.org/10.1590/S1806-37132015000004388.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Almagro M, Del Pozo J, Rodríguez-Lozano J, Silva JG, et al. Metastatic tuberculous abscesses in an immunocompetent patient. Clin Exp Dermatol. 2005;30(3):247–9. https://doi.org/10.1111/j.1365-2230.2005.01728.x.

    Article  CAS  PubMed  Google Scholar 

  63. Sezgin B, Atilganoglu U, Yigit O, Ergün SS, et al. Concomitant cutaneous metastatic tuberculous abscesses and multifocal skeletal tuberculosis. Indian J Dermatol. 2008;53(3):149–53. https://doi.org/10.4103/0019-5154.43208.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Gao W, Zeng Y, Chen W. Multiple subcutaneous tuberculous abscesses in a dermatomyositis patient without pulmonary tuberculosis: a case report and literature review. BMC Infect Dis. 2020;20:409. https://doi.org/10.1186/s12879-020-05137-w.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Daikos DL, Uttamchandani RB, Tuda C, Fischl MA, et al. Disseminated miliary tuberculosis of the skin in patients with AIDS. Clin Infect Dis. 1998;27(1):205–8. https://doi.org/10.1086/514608.

    Article  CAS  PubMed  Google Scholar 

  66. Sharma A, Pinto B, Dogra S, Sharma K, et al. A case series and review of Poncet’s disease, and the utility of current diagnostic criteria. Int J Rheum Dis. 2016;19:1010–7. https://doi.org/10.1111/1756-185X.12726.

    Article  PubMed  Google Scholar 

  67. Ramos-e-Silva M, Castro MCR. Mycobacterial infections. In: Bolognia JL, et al., editors. Dermatology. London: Elsevier; 2018. p. 1296–316. isbn:978-0-7020-6275-9.

    Google Scholar 

  68. Park YM, Kang H, Cho SH, Cho BK. Lichen scrofulosorum-like eruption localized to multipuncture BCG vaccination site. J Am Acad Dermatol. 1999;41(2):262–4. https://doi.org/10.1016/S0190-9622(99)70059-9.

    Article  CAS  PubMed  Google Scholar 

  69. Jacobsen G, Samolitis NJ, Harris RM. Lichenoid eruption in a patient with AIDS—Lichen scrofulosorum (LS) tuberculid with underlying MAC infection. Arch Dermatol. 2006;142(3):385–90. https://doi.org/10.1001/archderm.142.3.385-b.

    Article  PubMed  Google Scholar 

  70. Wong S, Rizvi H, Cerio R, O’Toole EA. An unusual case of vulval papulonecrotic tuberculid. Clin Exp Dermatol. 2011;36(3):277–80. https://doi.org/10.1111/j.1365-2230.2010.03925.x.

    Article  CAS  PubMed  Google Scholar 

  71. Freiman A, Ting P, Miller M, Greenway C. Papulonecrotic tuberculid: a rare form of cutaneous tuberculosis. Cutis. 2005;75(6):341–6. PMID: 16047872.

    PubMed  Google Scholar 

  72. Kim GW, Park HJ, Kim HS, Chin HW, et al. Simultaneous occurrence of papulonecrotic tuberculid and erythema induratum in a patient with pulmonary tuberculosis. Pediatr Dermatol. 2013;30(2):256–9. https://doi.org/10.1111/j.1525-1470.2012.01744.x.

    Article  PubMed  Google Scholar 

  73. Kim GW, Park HJ, Kim HS, Kim SH, et al. Delayed diagnosis of scrofuloderma misdiagnosed as a bacterial abscess. Ann Dermatol. 2012;24(1):70–3. https://doi.org/10.5021/ad.2012.24.1.70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. von Huth S, Ovrehus AL, Lindahl KH, Johansen IS. Two cases of erythema induratum of Bazin—a rare cutaneous manifestation of tuberculosis. Int J Infect Dis. 2015;38:121–4. https://doi.org/10.1016/j.ijid.2015.08.002.

    Article  Google Scholar 

  75. Mascaró JM Jr, Baselga E. Erythema induratum of Bazin. Dermatol Clin. 2008;26(4):439–45. https://doi.org/10.1016/j.det.2008.05.007.

    Article  PubMed  Google Scholar 

  76. Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnois and management. Dermatol Ther. 2010;23(4):320–7. https://doi.org/10.1111/j.1529-8019.2010.01332.x.

    Article  PubMed  Google Scholar 

  77. Sharon V, Goodarzi H, Chambers CJ, Fung MA, et al. Erythema induratum of Bazin. Dermatol Online J. 2010;16(4):1. PMID: 20409408.

    Article  PubMed  Google Scholar 

  78. Gupta V. Papulonecrotic tuberculid with scrofuloderma: an uncommon association. J Clin Diagn Res. 2015;9(2):WD03–4. https://doi.org/10.7860/JCDR/2015/10751.5524.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Magalhães TS, Dammert VG, Samorano LP, Litvoc MN, et al. Erythema induratum of Bazin: epidemiological, clinical and laboratorial profile of 54 patients. J Dermatol. 2018;45:628–9. https://doi.org/10.1111/1346-8138.14260.

    Article  PubMed  Google Scholar 

  80. Inoue T, Fukumoto T, Ansai S, Kimura T. Erythema induratum of Bazin in an infant after Bacille Calmette–Guerin vaccination. J Dermatol. 2006;33(4):268–72. https://doi.org/10.1111/j.1346-8138.2006.00065.x.

    Article  PubMed  Google Scholar 

  81. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Guidelines for tuberculosis control in Brazil. Brasilia; 2011. 284p. https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z-1/t/tuberculose. Accessed 23 Dec 2020.

  82. Almaguer-Chavez J, Ocampo-Candiani J, Rendon A. Current panorama in the diagnosis of cutaneous tuberculosis. Actas Dermosifiliogr. 2009;100(7):562–70. PMID: 19715641.

    Article  CAS  PubMed  Google Scholar 

  83. Tuberculin purified protein derivative (Tubersol®). PPD. https://www.drugs.com/pro/tubersol.html. Accessed 16 Dec 2020.

  84. Tuberculin purified protein derivative (Aplisol®). PPD. https://www.drugs.com/cdi/aplisol.html. Accessed 16 Dec 2020.

  85. Collins JM, Hunter M, Gordon W, Kempker RR, et al. False-positive tuberculin skin test results among low-risk healthcare workers following implementation of fifty-dose vials of purified protein derivative. Infect Control Hosp Epidemiol. 2018;39(6):750–2. https://doi.org/10.1017/ice.2018.59. PMID: 29606170; PMCID: PMC6393163.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10(11):1192–204. PMID: 17131776.

    CAS  PubMed  Google Scholar 

  87. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356(9235):1099–104. https://doi.org/10.1016/S0140-6736(00)02742-2.

    Article  CAS  PubMed  Google Scholar 

  88. Ramam M, Malhotra A, Tejasvi T, Manchanda Y, Sharma S, Mittal R, et al. How useful is the Mantoux test in the diagnosis of doubtful cases of cutaneous tuberculosis? Int J Dermatol. 2011;50(11):1379–82. https://doi.org/10.1111/j.1365-4632.2011.04971.x.

    Article  CAS  PubMed  Google Scholar 

  89. Seddon JA, Paton J, Nademi Z, Keane D, et al. The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection. Thorax. 2016;71(10):932–9. https://doi.org/10.1136/thoraxjnl-2015-207687. PMID: 27335104; PMCID: PMC5036222.

    Article  PubMed  Google Scholar 

  90. Mancuso JD, Mody RM, Olsen CH, Harrison LH, et al. The long-term effect of Bacille Calmette-Guérin vaccination on tuberculin skin testing: a 55-year follow-up study. Chest. 2017;152:282–94. https://doi.org/10.1016/j.chest.2017.01.001.

    Article  PubMed  Google Scholar 

  91. Carter ER, Lee CM. Interpretation of the tuberculin skin test reaction by pediatric providers. Pediatr Infect Dis J. 2002;21(3):200–3. https://doi.org/10.1097/00006454-200203000-00008. PMID: 12005082.

    Article  PubMed  Google Scholar 

  92. Grabau JC, Hughes SE, Foster EA, et al. False-positive tuberculin skin tests in a state prison system. Int J Tuberc Lung Dis. 2003;7(1):93–7. PMID: 12701841.

    CAS  PubMed  Google Scholar 

  93. de Medeiros VLS, Santos FCF, Montenegro LML, Silva MDC, et al. TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients. PLoS One. 2020;15(12):e0242098. https://doi.org/10.1371/journal.pone.0242098. PMID: 33270676; PMCID: PMC7714364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Arias-Guillén M, Sánchez Menéndez MM, Alperi M, Riestra S, et al. High rates of tuberculin skin test positivity due to methotrexate therapy: false positive results? Semin Arthritis Rheum. 2018;48(3):538–46. https://doi.org/10.1016/j.semarthrit.2018.03.018. PMID: 29735171.

    Article  CAS  PubMed  Google Scholar 

  95. Almeida Santos J, Duarte R, Nunes C. Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis. Clin Respir J. 2020;14(6):541–8. https://doi.org/10.1111/crj.13166. PMID: 32052551.

    Article  PubMed  Google Scholar 

  96. Lee YM, Park KH, Kim SM, Park SJ, et al. Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis. Infection. 2013;41(6):1089–95. https://doi.org/10.1007/s15010-013-0478-z. PMID: 23943073.

    Article  PubMed  Google Scholar 

  97. Assane K, Oumou NS, Mohamed C, Ndiaye ST, et al. Cutaneous tuberculosis in Dakar: 151 cases report. Mali Med. 2010;25(1):14–7. PMID: 21436010.

    PubMed  Google Scholar 

  98. Marcoval J, Servitje O, Moreno A, Jucglà A, Peyrí J. Lupus vulgaris. Clinical, histopathologic, and bacteriologic study of 10 cases. J Am Acad Dermatol. 1992;26(3 Pt 2):404–7. PMID: 1564144.

    Article  CAS  PubMed  Google Scholar 

  99. Mazurek GH, Jereb J, Vernon A, LoBue P, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1–25. PMID: 20577159.

    PubMed  Google Scholar 

  100. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, et al. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med. 2013;187(2):206–11. https://doi.org/10.1164/rccm.201203-0430OC.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Simsek H, Alpar S, Ucar N, Aksu F, et al. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis. Jpn J Infect Dis. 2010;63(2):99–102. PMID: 20332570.

    Article  PubMed  Google Scholar 

  102. Di L, Li Y. The risk factor of false-negative and false-positive for T-SPOT.TB in active tuberculosis. J Clin Lab Anal. 2018;32(2):e22273. https://doi.org/10.1002/jcla.22273. PMID: 28594104; PMCID: PMC6817182.

    Article  CAS  PubMed  Google Scholar 

  103. Yamasue M, Komiya K, Usagawa Y, Umeki K, et al. Factors associated with false-negative interferon-γ release assay results in patients with tuberculosis: a systematic review with meta-analysis. Sci Rep. 2020;10(1):1607. https://doi.org/10.1038/s41598-020-58459-9. PMID: 32005930; PMCID: PMC6994686.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Wang MS, Liu XJ. Risk factors for false-negative interferon-γ release assay results in culture-confirmed childhood TB. Am J Trop Med Hyg. 2019;101(6):1303–7. https://doi.org/10.4269/ajtmh.18-0684. PMID: 31674295; PMCID: PMC6896862.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Santos JA, Duarte R, Nunes C. Host factors associated with false-negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis. Pulmonology. 2020;26(6):353–62. https://doi.org/10.1016/j.pulmoe.2019.11.001. PMID: 31843341.

    Article  CAS  PubMed  Google Scholar 

  106. Kay AW, Islam SM, Wendorf K, Westenhouse J, Barry PM. Interferon-γ release assay performance for tuberculosis in childhood. Pediatrics. 2018;141(6):e20173918. https://doi.org/10.1542/peds.2017-3918. PMID: 29728429.

    Article  PubMed  Google Scholar 

  107. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177–84. https://doi.org/10.7326/0003-4819-149-3-200808050-00241.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Lai CC, Tan CK, Lin SH, Liu WL, et al. Diagnostic value of an enzyme-linked immunospot assay for interferon-γ in cutaneous tuberculosis. Diagn Microbiol Infect Dis. 2011;70(1):60–4. https://doi.org/10.1016/j.diagmicrobio.2010.11.012.

    Article  CAS  PubMed  Google Scholar 

  109. Cho K, Cho E, Kwon S, Im S, et al. Factors associated with indeterminate and false negative results of QuantiFERON-TB gold in-tube test in active tuberculosis. Tuberc Respir Dis (Seoul). 2012;72(5):416–25. https://doi.org/10.4046/trd.2012.72.5.416.

    Article  PubMed  Google Scholar 

  110. Chen Y, Jiang H, Zhang W, Chen Z, et al. Diagnostic value of T-SPOT.TB test in cutaneous mycobacterial infections. Acta Derm Venereol. 2018;98(10):989–90. https://doi.org/10.2340/00015555-3011. PMID: 30085325.

    Article  CAS  PubMed  Google Scholar 

  111. Chung HC, Kim BK, Hong H, Wang HY, et al. Interferon-γ release assay and reverse blot hybridization assay: diagnostic role in cutaneous tuberculosis. Acta Derm Venereol. 2016;96(1):126–7. https://doi.org/10.2340/00015555-2182. PMID: 26084370.

    Article  CAS  PubMed  Google Scholar 

  112. Vera-Kellet C, Peters L, Elwood K, Dutz JP. Usefulness of interferon- γ release assays in the diagnosis of erythema induratum. Arch Dermatol. 2011;147(8):949–52. https://doi.org/10.1001/archdermatol.2011.183.

    Article  CAS  PubMed  Google Scholar 

  113. Laffitte E, Janssens JP, Roux-Lombard P, Thielen AM, et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol. 2009;161(4):797–800. https://doi.org/10.1111/j.1365-2133.2009.09331.x.

    Article  CAS  PubMed  Google Scholar 

  114. Perez-Velez CM. Pediatric tuberculosis: new guidelines and recommendations. Curr Opin Pediatr. 2012;24(3):319–28. https://doi.org/10.1097/MOP.0b013e32835357c3.

    Article  PubMed  Google Scholar 

  115. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS. 2002;16(17):2285–93. https://doi.org/10.1097/00002030-200211220-00008.

    Article  PubMed  Google Scholar 

  116. Na SY, Park SY, Cho HH, Choi JW, et al. Application of IFN-γ releasing assay for the diagnosis of erythema induratum of Bazin. J Eur Acad Dermatol Venereol. 2014;28(1):41–5. https://doi.org/10.1111/jdv.12052. PMID: 23216422.

    Article  CAS  PubMed  Google Scholar 

  117. Koh HY, Tay LK, Pang SM, Ong BH. Changing the way we diagnose tuberculids with interferon-gamma release assays. Australas J Dermatol. 2012;53(1):73–5. https://doi.org/10.1111/j.1440-0960.2011.00791.x. PMID: 22309338.

    Article  PubMed  Google Scholar 

  118. El-Khalawany M, Meraag I, Eassa B, El-Naby HH. Clinicopathological features and the practice of diagnosing infectious cutaneous granulomas in Egypt. Int J Infect Dis. 2011;15(9):620–6. https://doi.org/10.1016/j.ijid.2011.04.014.

    Article  Google Scholar 

  119. Mann D, Sant’Anna FM, Schmaltz CAS, Rolla V, et al. Cutaneous tuberculosis in Rio de Janeiro, Brazil: description of a series of 75 cases. Int J Dermatol. 2019;58(12):1451–9. https://doi.org/10.1111/ijd.14617. PMID: 31553059.

    Article  PubMed  Google Scholar 

  120. Aggarwal P, Singal A, Bhattacharya SN, Mishra K. Comparison of the radiometric BACTEC 460 TB culture system and Lowenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern. Int J Dermatol. 2008;47(7):681–7. https://doi.org/10.1111/j.1365-4632.2008.03675.x.

    Article  PubMed  Google Scholar 

  121. Umapathy KC, Begum R, Ravichandran G, Rahman F, et al. Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis. Tropical Med Int Health. 2006;11:1521–8. https://doi.org/10.1111/j.1365-3156.2006.01705.x.

    Article  CAS  Google Scholar 

  122. Zouhair K, Akhdari N, Nejjam F, Ouazzani T, et al. Cutaneous tuberculosis in Morocco. Int J Infect Dis. 2007;11(3):209–12. https://doi.org/10.1016/j.ijid.2006.02.009.

    Article  PubMed  Google Scholar 

  123. Chong LY, Lo KK. Cutaneous tuberculosis in Hong Kong. A 10-year retrospective study. Int J Dermatol. 1995;34:26–9. https://doi.org/10.1111/j.1365-4362.1995.tb04372.x.

    Article  CAS  PubMed  Google Scholar 

  124. Abdalla CM, de Oliveira ZN, Sotto MN, Leite KR, et al. Polymerase chain reaction compared to other laboratory findings and to clinical evaluation in the diagnosis of cutaneous tuberculosis and atypical mycobacteria skin infection. Int J Dermatol. 2009;48(1):27–35. https://doi.org/10.1111/j.1365-4632.2009.03807.x.

    Article  CAS  PubMed  Google Scholar 

  125. Mei Y, Zhang W, Shi Y, Jiang H, et al. Cutaneous tuberculosis and nontuberculous mycobacterial infections at a National Specialized Hospital in China. Acta Derm Venereol. 2019;99(11):997–1003. https://doi.org/10.2340/00015555-3283. PMID: 31396633.

    Article  CAS  PubMed  Google Scholar 

  126. Coros A, DeConno E, Derbyshire KM. IS6110, a Mycobacterium tuberculosis complex-specific insertion sequence, is also present in the genome of Mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial species. J Bacteriol. 2008;190(9):3408–10. https://doi.org/10.1128/JB.00009-08.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Cortez MV, Oliveira CM, Monte RL, Araujo JR, et al. HIV-associated tuberculous lymphadenitis: the importance of polymerase chain reaction (PCR) as a complementary tool for the diagnosis of tuberculosis—a study of 104 patients. An Bras Dermatol. 2011;86(5):925–31. https://doi.org/10.1590/S0365-05962011000500010.

    Article  PubMed  Google Scholar 

  128. Barrios-Payan J, Saqui-Salces M, Jeyanathan M, Alcantara-Vazquez A, et al. Extrapulmonary locations of Mycobacterium tuberculosis DNA during latent infection. J Infect Dis. 2012;206(8):1194–205. https://doi.org/10.1093/infdis/jis381.

    Article  CAS  PubMed  Google Scholar 

  129. Tortoli E, Urbano P, Marcelli F, Simonetti TM, et al. Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples? J Clin Microbiol. 2012;50(8):2810–3. https://doi.org/10.1128/JCM.01412-12.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Goncalves MG, Fukasawa LO, Oliveira RS, Salgado MM, et al. Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR. Mem Inst Oswaldo Cruz. 2012;107(7):903–8. https://doi.org/10.1590/S0074-02762012000700011.

    Article  CAS  PubMed  Google Scholar 

  131. Afsar I, Afsar FS. Evaluation of laboratory diagnosis for cutaneous tuberculosis. Indian J Pathol Microbiol. 2016;59(3):274–8. https://doi.org/10.4103/0377-4929.188132. PMID: 27510659.

    Article  PubMed  Google Scholar 

  132. Agarwal P, Singh EN, Agarwal US, Meena R, et al. The role of DNA polymerase chain reaction, culture and histopathology in the diagnosis of cutaneous tuberculosis. Int J Dermatol. 2017;56(11):1119–24. https://doi.org/10.1111/ijd.13708. PMID: 28791686.

    Article  CAS  PubMed  Google Scholar 

  133. Malhotra S, Nair D, Ramesh V, Sehgal VN. Comparative evaluation of molecular tests Vis-à-Vis culture and treatment response in the diagnosis of cutaneous tuberculosis. Skinmed. 2018;16(5):301–3. PMID: 30413222.

    PubMed  Google Scholar 

  134. Suthar C, Rana T, Singh UB, Singh M, et al. mRNA and DNA PCR tests in cutaneous tuberculosis. Indian J Dermatol Venereol Leprol. 2013;79(1):65–9. https://doi.org/10.4103/0378-6323.104671. PMID: 23254731.

    Article  PubMed  Google Scholar 

  135. Maldonado-Bernal C, Ramos-Garibay A, Rios-Sarabia N, Serrano H, et al. Nested polymerase chain reaction and cutaneous tuberculosis. Am J Dermatopathol. 2019;41(6):428–35. https://doi.org/10.1097/DAD.0000000000001315. PMID: 30531542.

    Article  PubMed  Google Scholar 

  136. Tan SH, Tan HH, Sun YJ, Goh CL. Clinical utility of polymerase chain reaction in the detection of Mycobacterium tuberculosis in different types of cutaneous tuberculosis and tuberculids. Ann Acad Med Singap. 2001;30(1):3–10. PMID: 11242621.

    CAS  PubMed  Google Scholar 

  137. Hsiao PF, Tzen CY, Chen HC, Su HY. Polymerase chain reaction based detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Int J Dermatol. 2003;42(4):281–6. https://doi.org/10.1046/j.1365-4362.2003.01461.x.

    Article  CAS  PubMed  Google Scholar 

  138. Senturk N, Sahin S, Kocagoz T. Polymerase chain reaction in cutaneous tuberculosis: is it a reliable diagnostic method in paraffin-embedded tissues? Int J Dermatol. 2002;41(12):863–6. https://doi.org/10.1046/j.1365-4362.2002.01604.

    Article  CAS  PubMed  Google Scholar 

  139. Freitas FAD, Siqueira HR, Albano RM. Molecular methods in diagnosis of tuberculosis and resistance of Mycobacterium tuberculosis to drugs. Pulmao RJ. 2009;18(2):96–101.

    Google Scholar 

  140. Lucas S. Bacterial diseases. In: Elder DE, Elenitsas R, Murphy GF, et al., editors. Lever’s histopathology of the skin. 10th ed. Philadelphia: Lippincott; 2009. p. 513–50. isbn:9781451190373.

    Google Scholar 

  141. Zuñiga J, Torres-García D, Santos-Mendoza T, Rodriguez-Reyna TS, et al. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol. 2012;2012:193923. https://doi.org/10.1155/2012/193923.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Pai VV, Naveen KN, Athanikar SB, Dinesh US, et al. A clinico-histopathological study of lupus vulgaris: a 3 year experience at a tertiary care centre. Indian Dermatol Online J. 2014;5(4):461–5. https://doi.org/10.4103/2229-5178.142497.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Sharma S, Sehgal VN, Bhattacharya SN, Mahajan G, Gupta R. Clinicopathologic spectrum of cutaneous tuberculosis: a retrospective analysis of 165 Indians. Am J Dermatopathol. 2015;37(6):444–50. https://doi.org/10.1097/DAD.0000000000000297.

    Article  PubMed  Google Scholar 

  144. Yates VM, Walker SL. Chapter 27. Mycobacterial infections. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. 9th ed. Oxford: Blackwell Publishing Ltd; 2016. p. 27.5–27.47. isbn:9781118441190.

    Google Scholar 

  145. Singal A, Bhattacharya SN. Lichen scrofulosorum: a prospective study of 39 patients. Int J Dermatol. 2005;44(6):489–93. https://doi.org/10.1111/j.1365-4632.2005.02499.x.

    Article  PubMed  Google Scholar 

  146. Bilan P, Sin C, Wann AR, Grossin M, et al. Cutaneous tuberculosis and erythema induratum: a retrospective study of 13 cases in France. Ann Dermatol Venereol. 2015;142(4):237–44. https://doi.org/10.1016/j.annder.2015.01.015.

    Article  CAS  PubMed  Google Scholar 

  147. Jordaan HF, van Niekerk DJ, Louw M. Papulonecrotic tuberculid. A clinical, histopathological, and immunohistochemical study of 15 patients. Am J Dermatopathol. 1994;16(5):474–85. PMID: 7802163.

    Article  CAS  PubMed  Google Scholar 

  148. Choi SR, Kim JK, Kim DH, Yoon MS. A case of tuberculosis cutis orificialis with perianal involvement. Ann Dermatol. 2009;21(4):443–6. https://doi.org/10.5021/ad.2009.21.4.443.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Hadj I, Meziane M, Mikou O, Inani K, et al. Tuberculous gummas with sporotrichoid pattern in a 57-year-old female: a case report and review of the literature. Int J Mycobacteriol. 2014;3(1):66–70. https://doi.org/10.1016/j.ijmyco.2013.10.007.

    Article  CAS  PubMed  Google Scholar 

  150. Regnier S, Ouagari Z, Perez ZL, Veziris N, et al. Cutaneous miliary resistant tuberculosis in a patient infected with human immunodeficiency virus: case report and literature review. Clin Exp Dermatol. 2009;34(8):e690–2. https://doi.org/10.1111/j.1365-2230.2009.03425.x.

    Article  CAS  PubMed  Google Scholar 

  151. Thakur BK, Verma S, Hazarika D. A clinicopathological study of cutaneous tuberculosis at Dibrugarh District, Assam. Indian J Dermatol. 2012;57(1):63–5. https://doi.org/10.4103/0019-5154.92685.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Dwari BC, Ghosh A, Paudel R, Kishore P. A clinicoepidermiological study of 50 cases of cutaneous tuberculosis in a tertiary care teaching hospital in Pokhara, Nepal. Indian J Dermatol. 2010;55(3):233–7. https://doi.org/10.4103/0019-5154.70670.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Mathur M, Pandey SN. Clinico histological profile of cutaneous tuberculosis in Central Nepal. Kathmandu Univ Med J. 2014;12(4):238–41. https://doi.org/10.3126/kumj.v12i4.13727.

    Article  CAS  Google Scholar 

  154. Punia RS, Aggarwal P, Kundu R, Mohan H, et al. Cutaneous tuberculosis: a clinicopathological study of 50 cases from a tertiary care referral hospital. Appl Med Res. 2015;1(3):104–8. https://doi.org/10.5455/amr.20150412074909.

    Article  Google Scholar 

  155. Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacterioses. Hum Pathol. 1982;13(5):485–95. https://doi.org/10.1016/s0046-8177(82)80032-4.

    Article  CAS  PubMed  Google Scholar 

  156. Min KW, Ko JY, Park CK. Histopathological spectrum of cutaneous tuberculosis and non-tuberculous mycobacterial infections. J Cutan Pathol. 2012;39(6):582–95. https://doi.org/10.1111/j.1600-0560.2012.01903.x.

    Article  PubMed  Google Scholar 

  157. Paksoy N, Hekim E. Comparative analysis of the clinicopathological features in cutaneous leishmaniasis and lupus vulgaris in Turkey. Trop Med Parasitol. 1993;44(1):37–9. PMID: 8516631.

    CAS  PubMed  Google Scholar 

  158. Nirmala V, Chacko CJ, Job CK. Tuberculoid leprosy and tuberculosis skin: a comparative histopathological study. Lepr India. 1977;49(1):65–9. PMID: 895075.

    CAS  PubMed  Google Scholar 

  159. Leitao CCSL, Campelo ARL, Dantas AT. Tuberculose. In: Filgueira NA, Costa Jr JI, Lucena VG, Leitao CCS, Kitner D, Mendes JM, et al., editors. Condutas em clinica medica. 4th ed. Rio de Janeiro: Guanabara Koogan; 2007. p. 568–82.

    Google Scholar 

  160. Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva PG, Medeiros VLS. Cutaneous tuberculosis: diagnosis, histopathology and treatment—part II. An Bras Dermatol. 2014;89(4):545–55. https://doi.org/10.1590/abd1806-4841.20142747.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Nagarajan S, Whitaker P. Management of adverse reactions to first-line tuberculosis antibiotics. Curr Opin Allergy Clin Immunol. 2018;18(4):333–41. https://doi.org/10.1097/ACI.0000000000000462. PMID: 29901473.

    Article  CAS  PubMed  Google Scholar 

  162. Ramesh V, Sen MK, Sethuraman G, D’Souza P. Cutaneous tuberculosis due to multidrug-resistant tubercle bacilli and difficulties in clinical diagnosis. Indian J Dermatol Venereol Leprol. 2015;81(4):380–4. https://doi.org/10.4103/0378-6323.157447.

    Article  CAS  PubMed  Google Scholar 

  163. Arbex MA, Varella MCL, Siqueira HR, Mello FAF. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations—part 1: first-line drugs. J Bras Pneumol. 2010;36(5):626–40. https://doi.org/10.1590/S1806-37132010000500016.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Glossary

Acid-fast bacilli (AFB)

Testing may be used to detect several different types of acid-fast bacilli, but it is most commonly used to identify an active tuberculosis infection caused by the most medically important AFB, Mycobacterium tuberculosis. Are called acid-fast bacilli because they are rod-shaped bacteria (bacilli) that can be seen under the microscope following a staining procedure whereby the bacteria retain the color of the stain after an acid wash (acid-fast).

Bacille Calmette-Guérin (BCG)

Vaccine (strain 1331) is a live mycobacteria vaccine derived from attenuated strains of Mycobacterium bovis to prevent tuberculosis and other mycobacterial infections. BCG has been recommended only for immunocompetent children and adults who have high risk of ongoing exposure that cannot be avoided. In addition, it is used as an immunostimulant in the treatment of several diseases.

Erythema induratum of Bazin (EIB)

Is a granulomatous lobular panniculitis associated with tuberculosis, which affects the lower limbs of young and middle-aged women.

Erythema nodosum

Is characterized by the presence of nodular swelling, hardened, nonulcerative nodules which are seen predominantly in the lower limbs of women.

Interferon-γ release assay (IGRA)

Are tests used to identify indirectly a cellular immune response specific to peptides present in the MTB. Currently, there are two commercially available tests approved by the FDA, which use different techniques, the T-SPOT®.TB test and the QuantiFERON® TB Gold Plus (QFT-plus) test.

Lupus vulgaris

Is a chronic, progressive, and potentially disfiguring form of cutaneous tuberculosis, which occurs in patients with a high degree of immunity against Mycobacterium tuberculosis.

Scrofuloderma

Also known as tuberculosis colliquativa cutis, is the most common form of CTB in developing countries such as Brazil and India and can occur at any age, although children, adolescents, and the elderly are the most affected.

Tuberculids

Are considered hypersensitivity reactions to M. tuberculosis antigens present in extracutaneous focus or, rarely, after BCG vaccination.

Tuberculin skin test

(Mantoux technique, PPD, TST) technique consists in one injection of Purified Protein Derivative (PPD) of Mycobacterium tuberculosis in the superficial dermis, in the middle third of the left forearm. The TST is a delayed hypersensitivity type IV reaction induced by T lymphocytes.

Tuberculous gumma

Also called metastatic tuberculous abscess, is a multibacillary cutaneous tuberculosis. It results from the hematogenous dissemination of the bacillus by an active tuberculosis primary focus, especially in periods of decreased cellular immunity.

Tuberculosis verrucosa cutis

Is the most common form of exogenous cutaneous tuberculosis. The lesion develops from direct inoculation in the skin of previously sensitized individuals with moderate to high immunity against Mycobacterium tuberculosis.

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

dos Santos, J.B., de Oliveira, I.C.F., de Fátima Medeiros Brito, M., Carrera, M.C., Parisio, V.P., de Medeiros, V.L.S. (2023). Tuberculosis. In: Rangel Bonamigo, R. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-031-13505-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-13505-7_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-13504-0

  • Online ISBN: 978-3-031-13505-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics